Metraipolis › archive › dc_01b0984ca8cc

RIPK3 inhibitor GSK872 targets angiotensin II induced cardiomyocyte hypertrophy by regulating Ca2+/ calmodulin dependent protein kinase II — Europe PMC PMID:41499472

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41499472
DOI
10.1371/journal.pone.0334387
License (as archived)
solo-consultazione
Archived
2026-10-08T05:39:58.256Z
SHA-256 of the archived text
ae2643a936311deb984a4ebeb0034a66decfb4470727865ab72d0fcc70888f03
Stable URL of this page
https://metraipolis.com/documento/dc_01b0984ca8cc

How to cite

RIPK3 inhibitor GSK872 targets angiotensin II induced cardiomyocyte hypertrophy by regulating Ca2+/ calmodulin dependent protein kinase II — Europe PMC PMID:41499472 — Europe PMC (en), https://europepmc.org/article/MED/41499472 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_01b0984ca8cc (Metraipolis archive dc_01b0984ca8cc, sha256 ae2643a936311deb984a4ebeb0034a66decfb4470727865ab72d0fcc70888f03)
BibTeX
@misc{dc01b0984ca8cc,
  title = {RIPK3 inhibitor GSK872 targets angiotensin II induced cardiomyocyte hypertrophy by regulating Ca2+/ calmodulin dependent protein kinase II — Europe PMC PMID:41499472},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41499472},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_01b0984ca8cc; sha256 ae2643a936311deb984a4ebeb0034a66decfb4470727865ab72d0fcc70888f03},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41499472. Agents can read the archived copy with the MCP tool read_document.